Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil. (2022)

First Author: Cerqueira-Silva T
Attributed to:  Early Assessment of COVID-19 epidemiology and Vaccine/anti-viral Effectiveness (EAVE II) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41591-022-01701-w

PubMed Identifier: 35140406

Publication URI: http://europepmc.org/abstract/MED/35140406

Type: Journal Article/Review

Volume: 28

Parent Publication: Nature medicine

Issue: 4

ISSN: 1078-8956